3 cases of primary intracranial hemorrhage associated with Molly, a purified form of 3,4-methylenedioxymethamphetamine (MDMA)

D. Ethan Kahn, Nicholas Ferraro, Ronald J. Benveniste

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, or Ecstasy in tablet form) is a powerful sympathomimetic drug that is commonly perceived as safer than other stimulants such as methamphetamine or cocaine. Molly is a purified form of MDMA that is perceived by users as being even safer, as it is free of adulterants such as methamphetamine. Previously, all reports of intracranial hemorrhages in MDMA abusers were associated with coingestion of other sympathomimetic drugs, or with pre-existing cerebrovascular lesions. We describe a series of three young, otherwise healthy patients with various types of intracranial hemorrhages associated with Molly ingestion. All three patients underwent extensive workup including catheter angiography that did not demonstrate aneurysm, arteriovenous malformation, or vasculitis. We suggest that even the purified form of MDMA can cause serious intracranial hemorrhagic complications and should not be thought of as a safe recreational drug.

Original languageEnglish (US)
Pages (from-to)257-260
Number of pages4
JournalJournal of the Neurological Sciences
Volume323
Issue number1-2
DOIs
StatePublished - Dec 15 2012

Keywords

  • 3,4-Methylenedioxymethamphetamine (MDMA)
  • Ecstasy
  • Intracranial hemorrhage
  • Molly

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint Dive into the research topics of '3 cases of primary intracranial hemorrhage associated with Molly, a purified form of 3,4-methylenedioxymethamphetamine (MDMA)'. Together they form a unique fingerprint.

Cite this